Contact Us
Outpatient Oncology Infusion Global Market Report 2025
Global Outpatient Oncology Infusion Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Outpatient Oncology Infusion Global Market Report 2025

By Product (Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers), By End-User (Hospitals, Outpatient Clinics, Home Care Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Outpatient Oncology Infusion Market Overview

• Outpatient Oncology Infusion market size has reached to $12.99 billion in 2024

• Expected to grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Increasing Prevalence Of Cancer Cases Driving The Growth Of The Market Due To Aging Populations And Rising Cancer Risk

• Market Trend: Smart Syringe Infusion Pumps Enhancing Precision And Safety In Outpatient Therapy

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Outpatient Oncology Infusion Market?

Outpatient oncology infusion refers to the administration of cancer-fighting medications to patients in a non-hospital setting, such as infusion centers or clinics. Its purpose is to provide effective, convenient, and cost-efficient cancer treatment while allowing patients to avoid lengthy hospital stays.

The main product types of outpatient oncology infusion include infusion pumps, intravenous sets, intravenous cannulas, and needleless connectors. Infusion pumps are medical devices used to deliver controlled amounts of fluids, such as medications or nutrients, into a patient’s body over a specific period. These devices provide various therapies such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They are used in different applications, including lung cancer, liver cancer, breast cancer, prostate cancer, and others, and by various end users such as hospitals, outpatient clinics, and home care settings.

Outpatient Oncology Infusion Market Size and growth rate 2025 to 2029: Graph

What Is The Outpatient Oncology Infusion Market Size 2025 And Growth Rate?

The outpatient oncology infusion market size has grown strongly in recent years. It will grow from $12.99 billion in 2024 to $14.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising cancer incidence, expansion of outpatient centers, patient preference for home-like settings, increasing insurance coverage, shift from inpatient to outpatient care, and rising survival rates.

What Is The Outpatient Oncology Infusion Market Growth Forecast?

The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing elderly population, rising demand for personalized medicine, increasing use of biosimilars, focus on cost containment, value-based reimbursement models, and workforce shortages. Major trends in the forecast period include advancements in infusion devices, integration of telehealth services, technology-enabled remote patient monitoring, developments in personalized medicine, and advancements in targeted therapies.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Outpatient Oncology Infusion Market Segmented?

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, elastomeric infusion pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

What Is Driving The Outpatient Oncology Infusion Market? Increasing Prevalence Of Cancer Cases Driving The Growth Of The Market Due To Aging Populations And Rising Cancer Risk

The increasing prevalence of cancer cases is expected to propel the growth of the outpatient oncology infusion market going forward. Cancer is a group of complex diseases marked by the uncontrolled growth of abnormal cells, which can invade surrounding tissues and spread to other areas of the body. The prevalence of cancer cases is increasing primarily due to aging populations worldwide, as the risk of developing cancer rises significantly with age. Outpatient oncology infusion is used to administer cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical setting without requiring hospital admission, allowing patients to receive care while maintaining their daily routines. For instance, in April 2024, according to Macmillan Cancer Support, a UK-based charity providing practical, emotional, and financial support to people affected by cancer, it is projected that the number of individuals living with cancer in the UK will exceed 3 million presently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer cases is driving the growth of the outpatient oncology infusion industry.

Who Are The Major Players In The Global Outpatient Oncology Infusion Market?

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

What Are The Key Trends Of The Global Outpatient Oncology Infusion Market? Smart Syringe Infusion Pumps Enhancing Precision And Safety In Outpatient Therapy

Major companies operating in the outpatient oncology infusion market are focusing on innovative products such as syringe infusion pumps to enhance infusion accuracy, improve patient safety, and streamline medication delivery through advanced software and dose error reduction systems. A syringe infusion pump, also known as a syringe driver, is a motorized device designed to precisely control the flow of fluids by mechanically advancing or retracting the plunger of a syringe. For instance, in August 2022, Baxter International Inc., a US-based healthcare company specializing in surgical and intravenous infusion technologies, received U.S. Food and Drug Administration (FDA) clearance for the Novum IQ Syringe Infusion Pump (SYR), which is integrated with the Dose IQ Safety Software. This system utilizes Baxter’s advanced, web-based Dose IQ platform featuring a customizable drug library and a dose error reduction mechanism designed to support clinicians and healthcare institutions by centralizing real-time access to the latest medication data. Specifically intended for outpatient healthcare environments, including outpatient oncology infusion settings, the system delivers accurate, programmable infusions of therapeutic agents across diverse clinical care settings.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Outpatient Oncology Infusion Market? Strategic Acquisition Strengthens Fresenius Kabi’s Smart Infusion Portfolio

In March 2022, Fresenius Kabi AG, a Germany-based pharmaceuticals company, acquired Ivenix Inc. for $0.240 billion. The acquisition expands Fresenius Kabi’s infusion therapy portfolio with Ivenix’s innovative infusion system technology. Ivenix Inc. is a US-based medical device company specializing in innovative smart infusion pump systems used in outpatient and hospital settings, including oncology clinics.

What Is The Regional Outlook For The Global Outpatient Oncology Infusion Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Outpatient Oncology Infusion Industry?

The outpatient oncology infusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including the outpatient oncology infusion industry global market size, regional shares, competitors with the market share, detailed market segments, market trends, and opportunities, and any further data you may need to thrive in the outpatient oncology infusion industry. This outpatient oncology infusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Outpatient Oncology Infusion Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $14.02 billion
Revenue Forecast In 2034 $18.81 billion
Growth Rate CAGR of 7.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product, Therapy, Application, End-User, Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Outpatient Oncology Infusion Market Characteristics

3. Outpatient Oncology Infusion Market Trends And Strategies

4. Outpatient Oncology Infusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Outpatient Oncology Infusion Growth Analysis And Strategic Analysis Framework

5.1. Global Outpatient Oncology Infusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Outpatient Oncology Infusion Market Growth Rate Analysis

5.4. Global Outpatient Oncology Infusion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Outpatient Oncology Infusion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Outpatient Oncology Infusion Total Addressable Market (TAM)

6. Outpatient Oncology Infusion Market Segmentation

6.1. Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infusion Pumps

Intravenous Sets

Intravenous Cannulas

Needleless Connectors

6.2. Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy

6.3. Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Cancer

Liver Cancer

Breast Cancer

Prostate Cancer

Other Cancers

6.4. Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Outpatient Clinics

Home Care Settings

6.5. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Volumetric Infusion Pumps

Syringe Infusion Pumps

Elastomeric Infusion Pumps

Ambulatory Infusion Pumps

Smart Infusion Pumps

6.6. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vented IV Sets

Non-Vented IV Sets

Gravity IV Sets

Pump-Compatible IV Sets

Filtered IV Sets

6.7. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peripheral IV Cannulas

Central IV Cannulas

Winged IV Cannulas (Butterfly)

Closed IV Cannulas

Safety IV Cannulas

6.8. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Positive Displacement Connectors

Negative Displacement Connectors

Neutral Displacement Connectors

Closed System Transfer Devices (CSTDs)

Anti-Reflux Connectors

7. Outpatient Oncology Infusion Market Regional And Country Analysis

7.1. Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Outpatient Oncology Infusion Market

8.1. Asia-Pacific Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Outpatient Oncology Infusion Market

9.1. China Outpatient Oncology Infusion Market Overview

9.2. China Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Outpatient Oncology Infusion Market

10.1. India Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Outpatient Oncology Infusion Market

11.1. Japan Outpatient Oncology Infusion Market Overview

11.2. Japan Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Outpatient Oncology Infusion Market

12.1. Australia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Outpatient Oncology Infusion Market

13.1. Indonesia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Outpatient Oncology Infusion Market

14.1. South Korea Outpatient Oncology Infusion Market Overview

14.2. South Korea Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Outpatient Oncology Infusion Market

15.1. Western Europe Outpatient Oncology Infusion Market Overview

15.2. Western Europe Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Outpatient Oncology Infusion Market

16.1. UK Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Outpatient Oncology Infusion Market

17.1. Germany Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Outpatient Oncology Infusion Market

18.1. France Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Outpatient Oncology Infusion Market

19.1. Italy Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Outpatient Oncology Infusion Market

20.1. Spain Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Outpatient Oncology Infusion Market

21.1. Eastern Europe Outpatient Oncology Infusion Market Overview

21.2. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Outpatient Oncology Infusion Market

22.1. Russia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Outpatient Oncology Infusion Market

23.1. North America Outpatient Oncology Infusion Market Overview

23.2. North America Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Outpatient Oncology Infusion Market

24.1. USA Outpatient Oncology Infusion Market Overview

24.2. USA Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Outpatient Oncology Infusion Market

25.1. Canada Outpatient Oncology Infusion Market Overview

25.2. Canada Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Outpatient Oncology Infusion Market

26.1. South America Outpatient Oncology Infusion Market Overview

26.2. South America Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Outpatient Oncology Infusion Market

27.1. Brazil Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Outpatient Oncology Infusion Market

28.1. Middle East Outpatient Oncology Infusion Market Overview

28.2. Middle East Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Outpatient Oncology Infusion Market

29.1. Africa Outpatient Oncology Infusion Market Overview

29.2. Africa Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Outpatient Oncology Infusion Market Competitive Landscape And Company Profiles

30.1. Outpatient Oncology Infusion Market Competitive Landscape

30.2. Outpatient Oncology Infusion Market Company Profiles

30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Outpatient Oncology Infusion Market Other Major And Innovative Companies

31.1. Nipro Corporation

31.2. Smiths Medical Inc.

31.3. ICU Medical Inc.

31.4. B. Braun Melsungen AG

31.5. InfuSystem Holdings Inc.

31.6. BPL Medical Technologies Private Limited

31.7. Angiplast Private Limited

31.8. Bio-Med Healthcare Products Private Limited

31.9. Lars Medicare Private Limited

31.10. Micrel Medical Devices S.A.

31.11. AKAS Infusions Private Limited

31.12. Mais India Medical Devices Private Limited

31.13. Wellead Medical Co. Ltd.

31.14. AdvaCare Pharma USA LLC

31.15. Polymed Medical Devices Private Limited

32. Global Outpatient Oncology Infusion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Outpatient Oncology Infusion Market

34. Recent Developments In The Outpatient Oncology Infusion Market

35. Outpatient Oncology Infusion Market High Potential Countries, Segments and Strategies

35.1 Outpatient Oncology Infusion Market In 2029 - Countries Offering Most New Opportunities

35.2 Outpatient Oncology Infusion Market In 2029 - Segments Offering Most New Opportunities

35.3 Outpatient Oncology Infusion Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Medtronic plc Financial Performance
  • Table 80: Becton Dickinson and Company Financial Performance
  • Table 81: Baxter International Inc. Financial Performance
  • Table 82: Fresenius Kabi AG Financial Performance
  • Table 83: Terumo Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Medtronic plc Financial Performance
  • Figure 80: Becton Dickinson and Company Financial Performance
  • Figure 81: Baxter International Inc. Financial Performance
  • Figure 82: Fresenius Kabi AG Financial Performance
  • Figure 83: Terumo Corporation Financial Performance

Frequently Asked Questions

Outpatient oncology infusion refers to the administration of cancer-fighting medications to patients in a non-hospital setting, such as infusion centers or clinics. Its purpose is to provide effective, convenient, and cost-efficient cancer treatment while allowing patients to avoid lengthy hospital stays. For further insights on the Outpatient Oncology Infusion market, request a sample here

The Outpatient Oncology Infusion market major growth driver - Increasing Prevalence Of Cancer Cases Driving The Growth Of The Market Due To Aging Populations And Rising Cancer Risk. For further insights on the Outpatient Oncology Infusion market, request a sample here

The Outpatient Oncology Infusion market size has grown strongly in recent years. The outpatient oncology infusion market size has grown strongly in recent years. It will grow from $12.99 billion in 2024 to $14.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising cancer incidence, expansion of outpatient centers, patient preference for home-like settings, increasing insurance coverage, shift from inpatient to outpatient care, and rising survival rates. The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing elderly population, rising demand for personalized medicine, increasing use of biosimilars, focus on cost containment, value-based reimbursement models, and workforce shortages. Major trends in the forecast period include advancements in infusion devices, integration of telehealth services, technology-enabled remote patient monitoring, developments in personalized medicine, and advancements in targeted therapies. For further insights on the Outpatient Oncology Infusion market, request a sample here

The outpatient oncology infusion market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors For further insights on the Outpatient Oncology Infusion market,
request a sample here

North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Outpatient Oncology Infusion market, request a sample here.

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited. . For further insights on the Outpatient Oncology Infusion market, request a sample here.

Major trends in the Outpatient Oncology Infusion market include Smart Syringe Infusion Pumps Enhancing Precision And Safety In Outpatient Therapy. For further insights on the Outpatient Oncology Infusion market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon